According to the most recent financial data from March 2025, the current EPS (TTM) is $10.92. Idexx Laboratories's EPS for 2024 came in at $10.77, marking an increase from $10.17 in 2023. For the quarterly period ending on Mar 31, 2025, IDXX's EPS was $2.98.
Idexx Laboratories had an annual EPS of $10.77, marking an increase of 5.9% from $10.17 in 2023. The quarterly EPS for the period ending Mar 31, 2025, was $2.98, marking a 4.9% increase from the same quarter last year. IDXX's TTM EPS stands at $10.92 as of March 2025. Idexx Laboratories's EPS for 2023 stood at $10.17, a 25.2% increase from 2022.
Idexx Laboratories has recorded an increase in EPS of 4.9% over the last 12 months (YoY, quarterly). For the last three years, IDXX recorded an average annual EPS growth rate of 7.2%. Idexx Laboratories had an average annual EPS growth rate of 16.7% over the last 5 years. Across the last decade, IDXX had an average annual EPS growth of 19.5%.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
ABT Abbott Laboratories | 17.31 | 133.8% | 24.5% | 29.9% |
HSIC Henry Schein Inc | 23 | -3.5% | -12% | -8.2% |
TMO Thermo Fisher Scientific Inc | 25.2 | 6.8% | -5.5% | 12.4% |
IDXX Idexx Laboratories Inc | 49.55 | 5.9% | 7.2% | 16.7% |
NEOG Neogen Corp | N/A | 66.7% | N/A | N/A |
WOOF Petco Health & Wellness Company Inc | N/A | 92.3% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.